Langerhans Cell Histiocytosis Clinical Trials in Chengdu, Sichuan
3 recruitingChengdu, Sichuan, China
Showing 1–3 of 3 trials
Recruiting
Not Applicable
Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital62 enrolled11 locationsNCT07371182
Recruiting
Phase 2
Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital20 enrolled1 locationNCT07022834
Recruiting
Phase 2
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
Langerhans Cell HistiocytosisLCH
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.56 enrolled11 locationsNCT05997602